These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16899063)

  • 21. Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172.
    Fegley D; Kathuria S; Mercier R; Li C; Goutopoulos A; Makriyannis A; Piomelli D
    Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8756-61. PubMed ID: 15138300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A cyclooxygenase metabolite of anandamide causes inhibition of interleukin-2 secretion in murine splenocytes.
    Rockwell CE; Kaminski NE
    J Pharmacol Exp Ther; 2004 Nov; 311(2):683-90. PubMed ID: 15284281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of palmitoylethanolamide transport in mouse Neuro-2a neuroblastoma and rat RBL-2H3 basophilic leukaemia cells: comparison with anandamide.
    Jacobsson SO; Fowler CJ
    Br J Pharmacol; 2001 Apr; 132(8):1743-54. PubMed ID: 11309246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis and biological evaluation of new endocannabinoid transporter inhibitors.
    López-Rodríguez ML; Viso A; Ortega-Gutiérrez S; Fowler CJ; Tiger G; de Lago E; Fernández-Ruiz J; Ramos JA
    Eur J Med Chem; 2003 Apr; 38(4):403-12. PubMed ID: 12750028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake.
    de Lago E; Ligresti A; Ortar G; Morera E; Cabranes A; Pryce G; Bifulco M; Baker D; Fernandez-Ruiz J; Di Marzo V
    Eur J Pharmacol; 2004 Jan; 484(2-3):249-57. PubMed ID: 14744610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of inhibition of fatty acid amide hydrolase vs. the anandamide membrane transporter on TRPV1-mediated calcium responses in adult DRG neurons; the role of CB receptors.
    Millns PJ; Chimenti M; Ali N; Ryland E; de Lago E; Fernandez-Ruiz J; Chapman V; Kendall DA
    Eur J Neurosci; 2006 Dec; 24(12):3489-95. PubMed ID: 17229097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats.
    Nucci C; Gasperi V; Tartaglione R; Cerulli A; Terrinoni A; Bari M; De Simone C; Agrò AF; Morrone LA; Corasaniti MT; Bagetta G; Maccarrone M
    Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):2997-3004. PubMed ID: 17591864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin.
    Holt S; Paylor B; Boldrup L; Alajakku K; Vandevoorde S; Sundström A; Cocco MT; Onnis V; Fowler CJ
    Eur J Pharmacol; 2007 Jun; 565(1-3):26-36. PubMed ID: 17397826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversible, temperature-dependent, and AM404-inhibitable adsorption of anandamide to cell culture wells as a confounding factor in release experiments.
    Karlsson M; Påhlsson C; Fowler CJ
    Eur J Pharm Sci; 2004 Jun; 22(2-3):181-9. PubMed ID: 15158903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors.
    Melck D; Bisogno T; De Petrocellis L; Chuang H; Julius D; Bifulco M; Di Marzo V
    Biochem Biophys Res Commun; 1999 Aug; 262(1):275-84. PubMed ID: 10448105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and characterization of a fluorescent substrate for the N-arachidonoylethanolamine (anandamide) transmembrane carrier.
    Muthian S; Nithipatikom K; Campbell WB; Hillard CJ
    J Pharmacol Exp Ther; 2000 Apr; 293(1):289-95. PubMed ID: 10734181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of anandamide transport inhibitor AM404 on voltage-dependent calcium channels.
    Alptekin A; Galadari S; Shuba Y; Petroianu G; Oz M
    Eur J Pharmacol; 2010 May; 634(1-3):10-5. PubMed ID: 20171208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of fatty acid amidohydrolase, the enzyme responsible for the metabolism of the endocannabinoid anandamide, by analogues of arachidonoyl-serotonin.
    Fowler CJ; Tiger G; López-Rodríguez ML; Viso A; Ortega-Gutiérrez S; Ramos JA
    J Enzyme Inhib Med Chem; 2003 Jun; 18(3):225-31. PubMed ID: 14506913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anandamide uptake is consistent with rate-limited diffusion and is regulated by the degree of its hydrolysis by fatty acid amide hydrolase.
    Kaczocha M; Hermann A; Glaser ST; Bojesen IN; Deutsch DG
    J Biol Chem; 2006 Apr; 281(14):9066-75. PubMed ID: 16461355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The anandamide transport inhibitor AM404 reduces ethanol self-administration.
    Cippitelli A; Bilbao A; Gorriti MA; Navarro M; Massi M; Piomelli D; Ciccocioppo R; Rodríguez de Fonseca F
    Eur J Neurosci; 2007 Jul; 26(2):476-86. PubMed ID: 17650118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: comparison with effects on fatty acid amidohydrolase.
    López-Rodríguez ML; Viso A; Ortega-Gutiérrez S; Fowler CJ; Tiger G; de Lago E; Fernández-Ruiz J; Ramos JA
    J Med Chem; 2003 Apr; 46(8):1512-22. PubMed ID: 12672252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of endocannabinoid system-modulating N-alkylamides from Heliopsis helianthoides var. scabra and Lepidium meyenii.
    Hajdu Z; Nicolussi S; Rau M; Lorántfy L; Forgo P; Hohmann J; Csupor D; Gertsch J
    J Nat Prod; 2014 Jul; 77(7):1663-9. PubMed ID: 24972328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-Morpholino- and N-diethyl-analogues of palmitoylethanolamide increase the sensitivity of transfected human vanilloid receptors to activation by anandamide without affecting fatty acid amidohydrolase activity.
    Vandevoorde S; Lambert DM; Smart D; Jonsson KO; Fowler CJ
    Bioorg Med Chem; 2003 Mar; 11(6):817-25. PubMed ID: 12614867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity.
    De Petrocellis L; Bisogno T; Davis JB; Pertwee RG; Di Marzo V
    FEBS Lett; 2000 Oct; 483(1):52-6. PubMed ID: 11033355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of anandamide transport in FAAH wild-type and knockout neurons: evidence for contributions by both FAAH and the CB1 receptor to anandamide uptake.
    Ortega-Gutiérrez S; Hawkins EG; Viso A; López-Rodríguez ML; Cravatt BF
    Biochemistry; 2004 Jun; 43(25):8184-90. PubMed ID: 15209515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.